0000-0002-8374-4536 Employment
-
G.D Hospital & Diabetes Institute M.D (Medicine); D.M (Endocrinology), Consultant Endocrinologist
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (85)
- Short‐Term HbA1c Non‐Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability Save
- Synthetic Versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims Save
- Inadvertent glucagon-like peptide-1 receptor agonist exposure in pregnancy: reassuring data, unresolved safety (letter to the editor) Save
- Efficacy and safety of fixed-dose dapagliflozin–pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trial Save
- Periconceptional GLP-1 Receptor Agonist Exposure Save
- Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5–15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials Save
- Metformin in prediabetes: Opportunity or over-treatment? Save
- Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence Save
- An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update Save
- Role of newer anti-diabetes drugs in prediabetes: A systematic review Save